3 Recruiting Primary Central Nervous System Lymphoma Phase 1 Clinical Trials

Active phase 1 studies for primary central nervous system lymphoma enrolling across the USA. Verify eligibility and contact site coordinators.

All Primary Central Nervous System Lymphoma studies

Phase 1 Studies for Primary Central Nervous System Lymphoma

🔵 Active, Not Recruiting Phase1

Phase 1 Study of Ibrutinib and Immuno-Chemotherapy Using Temozolomide, Etoposide, Doxil, Dexamethasone, Ibrutinib,Rituximab (TEDDI-R) in Primary CNS Lymphoma

📍 National Institutes of Health Clinical Center — Bethesda, Maryland

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase1

Acalabrutinib and Durvalumab in Primary and Secondary Central Nervous System Lymphoma

📍 Washington University School of Medicine — St Louis, Missouri

View Study & Checklist ➔

🟢 Recruiting Phase1 / Phase2

Pembrolizumab, Ibrutinib and Rituximab in PCNSL

📍 Dana Farber Cancer Institute — Boston, Massachusetts

View Study & Checklist ➔